| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
|
Tanaka, Atsushi
|
|
|
140 |
8 |
p. 875-888
|
artikel
|
| 2 |
Anticoagulation in hospitalized patients with COVID-19
|
Baumann Kreuziger, Lisa
|
|
|
140 |
8 |
p. 809-814
|
artikel
|
| 3 |
An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database
|
Fuentes, Ségolène
|
|
|
140 |
8 |
p. 922-927
|
artikel
|
| 4 |
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
|
Klatt, Martin G.
|
|
|
140 |
8 |
p. 861-874
|
artikel
|
| 5 |
CAR-T for follicular lymphoma: are we good to go?
|
Gasiorowski, Robin
|
|
|
140 |
8 |
p. 799-800
|
artikel
|
| 6 |
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
|
Ghione, Paola
|
|
|
140 |
8 |
p. 851-860
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
140 |
8 |
p. i
|
artikel
|
| 8 |
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
|
Seymour, John F.
|
|
|
140 |
8 |
p. 839-850
|
artikel
|
| 9 |
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes
|
McReynolds, Lisa J.
|
|
|
140 |
8 |
p. 909-921
|
artikel
|
| 10 |
How I approach smoldering multiple myeloma
|
Vaxman, Iuliana
|
|
|
140 |
8 |
p. 828-838
|
artikel
|
| 11 |
Immunosuppressive lung neutrophils
|
Kolaczkowska, Elzbieta
|
|
|
140 |
8 |
p. 802-803
|
artikel
|
| 12 |
Mutant SF3B1 splices a more leukemogenic EVI1
|
Obeng, Esther A.
|
|
|
140 |
8 |
p. 800-801
|
artikel
|
| 13 |
Numerous B cells in a mediastinal mass, but not a B-cell lymphoma
|
Venkataraman, Girish
|
|
|
140 |
8 |
p. 932
|
artikel
|
| 14 |
Playing with fire: unrecognized AA genetic predisposition
|
DeZern, Amy E.
|
|
|
140 |
8 |
p. 805-807
|
artikel
|
| 15 |
Rivaroxaban after laparoscopic cancer surgery
|
Soff, Gerald A.
|
|
|
140 |
8 |
p. 804-805
|
artikel
|
| 16 |
Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer
|
Becattini, Cecilia
|
|
|
140 |
8 |
p. 900-908
|
artikel
|
| 17 |
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
|
Heiblig, Maël
|
|
|
140 |
8 |
p. 927-931
|
artikel
|
| 18 |
Ruxolitinib takes center stage for VEXAS syndrome
|
Conway, Richard
|
|
|
140 |
8 |
p. 807-808
|
artikel
|
| 19 |
The multifaceted role of platelets in mediating brain function
|
Burnouf, Thierry
|
|
|
140 |
8 |
p. 815-827
|
artikel
|
| 20 |
uMRD: “the” endpoint or “an” endpoint for CLL?
|
Kittai, Adam S.
|
|
|
140 |
8 |
p. 797-798
|
artikel
|
| 21 |
Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling
|
Bae, Geon Ho
|
|
|
140 |
8 |
p. 889-899
|
artikel
|
Tijdschrift beschrijving